Ashworth A - Search Results

1

Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, Zelenika D, Gut I, Heath S, Palles C, Coupland B, Broderick P, Schoemaker M, Jones M, Williamson J, Chilcott-Burns S, Tomczyk K, Simpson G, Jacobs KB, Chanock SJ, Hunter DJ, Tomlinson IP, Swerdlow A, Ashworth A, Ross G, dos Santos Silva I, Lathrop M, Houlston RS, Peto J. Fletcher O, et al. Among authors: ashworth a. J Natl Cancer Inst. 2011 Mar 2;103(5):425-35. doi: 10.1093/jnci/djq563. Epub 2011 Jan 24. J Natl Cancer Inst. 2011. PMID: 21263130

2

Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification.

Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G, Ashworth A. Tutt A, et al. Among authors: ashworth a. Curr Biol. 1999 Oct 7;9(19):1107-10. doi: 10.1016/s0960-9822(99)80479-5. Curr Biol. 1999. PMID: 10531007 Free article.

3

Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences.

Tutt A, Bertwistle D, Valentine J, Gabriel A, Swift S, Ross G, Griffin C, Thacker J, Ashworth A. Tutt A, et al. Among authors: ashworth a. EMBO J. 2001 Sep 3;20(17):4704-16. doi: 10.1093/emboj/20.17.4704. EMBO J. 2001. PMID: 11532935 Free PMC article.

4

Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation.

Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A. Tutt AN, et al. Among authors: ashworth a. EMBO Rep. 2002 Mar;3(3):255-60. doi: 10.1093/embo-reports/kvf037. Epub 2002 Feb 15. EMBO Rep. 2002. PMID: 11850397 Free PMC article.

5

Molecular profiling of breast cancer: clinical implications.

Cleator S, Ashworth A. Cleator S, et al. Among authors: ashworth a. Br J Cancer. 2004 Mar 22;90(6):1120-4. doi: 10.1038/sj.bjc.6601667. Br J Cancer. 2004. PMID: 15026788 Free PMC article. Review.

6

Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.

Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S. Fletcher O, et al. Among authors: ashworth a. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):2-19. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668470 Review.

7

BRCA1 and BRCA2 as ovarian cancer susceptibility genes.

Sowter HM, Ashworth A. Sowter HM, et al. Among authors: ashworth a. Carcinogenesis. 2005 Oct;26(10):1651-6. doi: 10.1093/carcin/bgi136. Epub 2005 May 25. Carcinogenesis. 2005. PMID: 15917310

8

Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study.

Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos Silva I, Ashworth A, Peto J. Johnson N, et al. Among authors: ashworth a. Lancet. 2005 Oct 29-Nov 4;366(9496):1554-7. doi: 10.1016/S0140-6736(05)67627-1. Lancet. 2005. PMID: 16257342 Review.

9

Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk.

Fletcher O, Johnson N, Palles C, dos Santos Silva I, McCormack V, Whittaker J, Ashworth A, Peto J. Fletcher O, et al. Among authors: ashworth a. J Natl Cancer Inst. 2006 Jul 19;98(14):1014-8. doi: 10.1093/jnci/djj268. J Natl Cancer Inst. 2006. PMID: 16849685

10

BRCA1 dysfunction in sporadic basal-like breast cancer.

Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, Savage K, Gillett CE, Schmitt FC, Ashworth A, Tutt AN. Turner NC, et al. Among authors: ashworth a. Oncogene. 2007 Mar 29;26(14):2126-32. doi: 10.1038/sj.onc.1210014. Epub 2006 Oct 2. Oncogene. 2007. PMID: 17016441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

825 results

Search Page